Arq. Bras. Oftalmol. 2021; 84 (1): 10.5935/0004-2749.20210003
Total: 2822
Rodrigo Teixeira Santos; Bernardo Kaplan Moscovici; Flávio Eduardo Hirai; Cláudia Maria Francesconi Benício; Eliane Mayumi Nakano; Walton Nosé
DOI: 10.5935/0004-2749.20210003
Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
Corresponding authorRodrigo Teixeira Santos
E-mail: [email protected]
Funding: This study received no specific financial support.
Disclosure of potential conflicts of interest: Walton Nosé is a consultant of ALCON - a Novartis Division. Rodrigo Teixeira Santos, Bernardo Kaplan Moscovici, Flávio Hirai, Cláudia Maria Francesconi Benício, and Eliane Mayumi Nakano have no conflicts of interest to declare.
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
